S. 1622 (114th): FDA Device Accountability Act of 2016
A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to devices.
The bill’s titles are written by its sponsor.
Overview
- Introduced:
Jun 18, 2015
114th Congress, 2015–2017- Status:
-
Died in a previous Congress
This bill was introduced on February 9, 2016, in a previous session of Congress, but was not enacted.
- Sponsor:
-
- Text:
-
Read Text »
Last Updated: Apr 18, 2016
Length: 14 pages
History
|
|
|
Introduced
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber. |
|
|
|
Ordered Reported
A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee. |
S. 1622 (114th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 114th Congress, which met from Jan 6, 2015 to Jan 3, 2017. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
“S. 1622 — 114th Congress: FDA Device Accountability Act of 2016.” www.GovTrack.us. 2015. June 24, 2017 <https://www.govtrack.us/congress/bills/114/s1622>
- show another citation format:
- APA
- Wikipedia Template
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.